Clinical trials

Recherche d’études cliniques

Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.

Réinitialiser

Études cliniques 643

Étude / NCT ⇅ Molécule ⇅ Maladie ⇅ Phase ⇅ Statut ⇅ Résultat ⇅ Sponsor ⇅ Pays / centres ⇅ Période ⇅ Détail
NCT01708655
Sweat Evaporimeter Measurement
Sweat Evaporimeter Measurement SEP Non applicable COMPLETED En attente / non publié University of Colorado, Denver United States · Children's Hospital Colorado, Aurora,… 2011-12 → 2014-12 Ouvrir
NCT06553391
Heart Rhythm Changes in Patients With Atrial Fibrillation After Cardiop…
The tetralogy of medication regim… SEP À vérifier COMPLETED En attente / non publié Chinese Academy of Medical Scienc… China · Fuwai Hospital, Chinese Academy of Medical Sc… 2024-08-01 → 2025-05-30 Ouvrir
NCT00492518
ATHENS — Acetylcysteine, Theophylline, and a Combination of Both in the…
Acetylcysteine SEP Phase 4 COMPLETED En attente / non publié Technical University of Munich Germany · Klinikum Rechts der Isar; Technical Univers… 2002-02 → 2004-10 Ouvrir
NCT01587027
Safety Evaluation of Aminophylline and Methazolamide
Aminophylline SEP Phase 1 COMPLETED En attente / non publié Shanghai Jiao Tong University Aff… United States · Medical Center of the Rockies, Lovela… 2011-12 → 2012-02 Ouvrir
NCT02273440
Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Health…
BIIL 284 BS SEP Phase 1 COMPLETED En attente / non publié Boehringer Ingelheim Non communiqué 2000-05 Ouvrir
NCT05292339
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
Triamcinolone injection to the sh… Myopathies Phase 4 RECRUITING En attente / non publié Emory University United States · 12 Executive Park Drive, Atlanta, Uni… 2023-01-31 → 2027-07 Ouvrir
NCT07143461
Effects of Prayer on Pain Thresholds and Scores of Anxiety and Depressi…
Effects of Prayer on Pain Thresho… Migraine Non applicable COMPLETED En attente / non publié University of Sao Paulo Brazil · Institute of Psychiatry of the University of… 2023-09-29 → 2025-09-29 Ouvrir
NCT01174498
Pilot Study of the Effect of Transcutaneous Stimulation of the Vagus Ne…
Cerbomed t-VNS® transcutaneous st… SEP Non applicable COMPLETED En attente / non publié cerbomed GmbH Germany · Klinik und Poliklinik für Psychiatrie und P… 2009-11 → 2010-09 Ouvrir
NCT06953388
SPARK-VNS — Understanding Non-invasive Vagus Nerve Stimulation Effects …
transcutaneous auricular vagus ne… SEP Phase 1 NOT_YET_RECRUITING En attente / non publié Xijing Hospital United States · Tolan Park Research Clinic, Wayne Sta… 2027-04-01 → 2031-03-01 Ouvrir
NCT05301140
Vivistim Registry for Paired VNS Therapy (GRASP)
Vivistim System SEP À vérifier RECRUITING En attente / non publié MicroTransponder Inc. United States · Advent Health Orlando, Orlando, Unite… 2023-03-15 → 2028-12-31 Ouvrir
NCT00215215
Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS …
Vagus Nerve Stimulation Therapy SEP Phase 4 TERMINATED En attente / non publié Cyberonics, Inc. United States · Bronislav Shafran, M.D., P.C., Phoeni… 2005-02 → 2007-11 Ouvrir
NCT06985043
The Effect of Vagus Nerve Stimulation on Lower Limb Muscle Strength and…
Auricular vagus nerve stimulation… SEP Non applicable COMPLETED En attente / non publié Bahçeşehir University Turkey (Türkiye) · Bahcesehir university, Istanbul, T… 2025-05-25 → 2025-07-25 Ouvrir
NCT01118455
Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug…
Vagus Nerve Stimulation (VNS) The… SEP Phase 4 TERMINATED En attente / non publié Cyberonics, Inc. Austria, Belgium, Germany, Sweden, United Kingdom · A… 2004-10 → 2010-01 Ouvrir
NCT03440255
Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center
transcutaneous vagus nerve stimul… SEP Non applicable COMPLETED En attente / non publié Kyoungwon Baik Canada · Kinesis Health Associates, Dartmouth, Canada 2017-07-01 → 2017-09-15 Ouvrir
NCT05967598
Effect of taVNS of Brainstem Activation in Early and Late Parkinson's D…
Noninvasive transcutaneous auricu… SEP Non applicable COMPLETED En attente / non publié University of Ljubljana Slovenia · Neurology Department, UMC Ljubljana, Ljubl… 2023-02-15 → 2023-09-29 Ouvrir
NCT06865274
PoGe — Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromye…
Blood draw for the laboratory ass… SEP Non applicable RECRUITING En attente / non publié Fondazione Policlinico Universita… Italy · Fondazione Policlinico Universitario Agostino… 2025-02-20 → 2027-02-28 Ouvrir
NCT05902429
CLAREMI — Effects of Oral Cladribine on Remyelination and Inflammation …
Cladribine 10 mg oral tablet SEP Phase 4 UNKNOWN En attente / non publié Pontificia Universidade Católica … Brazil · Pontifical Catholic University of Rio Grande… 2021-04-28 → 2024-08 Ouvrir
NCT02446886
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects W…
Adrenocorticotropic hormone (ACTH… SEP Phase 4 TERMINATED En attente / non publié Weill Medical College of Cornell … United States · Weill Cornell Medicine, New York, Uni… 2016-06 → 2020-06 Ouvrir
NCT07653984
RANID — Cohort Study on Neuroimmune Diseases in the Reproductive Age
RANID — Cohort Study on Neuroimmu… SEP À vérifier RECRUITING En attente / non publié Third Affiliated Hospital, Sun Ya… China · The Third Affiliated Hospital, Sun Yat-sen Un… 2024-04-21 → 2030-04 Ouvrir
NCT05746845
RESEPTOR 5-HT7 — Implication of 5-HT7 Receptor in Inflammatory Mechanis…
Blood sample SEP À vérifier COMPLETED En attente / non publié Centre Hospitalier Régional d'Orl… France · CHU Orléans, Orléans, France 2023-03-06 → 2024-07-01 Ouvrir
NCT02861014
A Study of Ocrelizumab in Participants With Relapsing Remitting Multipl…
Ocrelizumab SEP Phase 3 COMPLETED En attente / non publié Hoffmann-La Roche Australia, Belgium, Czechia, Denmark, Estonia, Finlan… 2016-09-09 → 2020-12-15 Ouvrir
NCT04902690
The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Exp…
The Possible Neuroprotective Effe… SEP À vérifier UNKNOWN En attente / non publié IRCCS National Neurological Insti… Non communiqué 2021-05-31 → 2024-07-31 Ouvrir
NCT04863586
COVID-19 and Multiple Sclerosis Disease Modifying Therapies
COVID-19 and Multiple Sclerosis D… SEP À vérifier UNKNOWN En attente / non publié Nottingham University Hospitals N… United Kingdom · Nottingham University Hospitals NHS … 2021-04-01 → 2022-05-31 Ouvrir
NCT05208840
LEGATO — A Study To Determine The Effect Of Ocrelizumab On Leptomeninge…
Ocrelizumab SEP Phase 4 WITHDRAWN En attente / non publié Hoffmann-La Roche Russia · City Clinical Hospital #24; Multipal Scleros… 2023-09-15 → 2026-01-31 Ouvrir
NCT07380022
PHYTASE — Acceptability, Adherence, and Impact on the Bioavailability o…
PHYTASE — Acceptability, Adherenc… SEP Non applicable COMPLETED En attente / non publié University of Thessaly Greece · School of Physical Education, Sport Science … 2025-07-09 → 2026-02-28 Ouvrir